Skip to main content

multiGSEA: a GSEA-based pathway enrichment analysis for multi-omics data

Abstract

Background

Gaining biological insights into molecular responses to treatments or diseases from omics data can be accomplished by gene set or pathway enrichment methods. A plethora of different tools and algorithms have been developed so far. Among those, the gene set enrichment analysis (GSEA) proved to control both type I and II errors well. In recent years the call for a combined analysis of multiple omics layers became prominent, giving rise to a few multi-omics enrichment tools. Each of these has its own drawbacks and restrictions regarding its universal application.

Results

Here, we present the multiGSEA package aiding to calculate a combined GSEA-based pathway enrichment on multiple omics layers. The package queries 8 different pathway databases and relies on the robust GSEA algorithm for a single-omics enrichment analysis. In a final step, those scores will be combined to create a robust composite multi-omics pathway enrichment measure. multiGSEA supports 11 different organisms and includes a comprehensive mapping of transcripts, proteins, and metabolite IDs.

Conclusions

With multiGSEA we introduce a highly versatile tool for multi-omics pathway integration that minimizes previous restrictions in terms of omics layer selection, pathway database availability, organism selection and the mapping of omics feature identifiers. multiGSEA is publicly available under the GPL-3 license at https://github.com/yigbt/multiGSEA and at bioconductor: https://bioconductor.org/packages/multiGSEA.

Background

When measuring molecular responses to a certain treatment or gaining insights into clinical phenotypes, gene set or pathway enrichment techniques are tools of first choice to infer mechanistic biological information from high-dimensional molecular omics data. Through different statistical techniques, such as over-representation analysis (ORA) or gene set enrichment analysis (GSEA), these methods are capable of identifying specific sets of genes or molecular response/signaling pathways that are triggered upon a certain treatment or disease. These sets might represent specific molecular functions, as defined by Gene Ontology (GO) [1], biological processes or experimentally derived gene sets which are publicly available in databases such as Reactome [2] or the Molecular Signature Database (MSigDB) [3].

Up to date nearly one hundred algorithms have been developed for gene set or pathway enrichment, each of which has its own strengths and weaknesses. In principle, these methods can be grouped into two distinct classes: (1) pure gene set enrichment, where the algorithms solely focus on a plain list of features and (2) topology-based enrichment, where algorithms include additional information derived from pathway or network databases, e.g., which genes or proteins are directly connected and how they influence each other. There are several comprehensive reviews on this topic available, see for example [4, 5]. Besides a plain quality assessment of different enrichment techniques, this review also evaluated the robustness of available methods, i.e., how error-prone these methods are w.r.t. the prediction of either false positive or false negative gene sets or pathways. The popular GSEA method showed a decent quality in terms of rank- and p value-based pathway enrichment but moreover was the only method not found to produce any false prediction [5].

Over the last decade, combined analysis of molecular responses through the integration of multiple omics types has become prevalent, e.g. combining transcriptomics, proteomics, and metabolomics. This is becoming necessary since single-omics analyses will only measure biomolecules of a specific type and will often not even detect its entirety but only a subset thereof. Furthermore, the response time and the life-span of biomolecules varies substantially within and between single omics layers. Thus, only the combined analysis of several molecular layers through multi-omics measurements reliably allows to uncover a significant fraction of cellular effects [6].

There are a few integration tools available that incorporate pathway knowledge to interpret multi-omics datasets like PaintOmics [7] or IMPaLA [8]. These methods exhibit several limitations hampering their unrestricted application. PaintOmics, for example, is capable of including several different omics layers into its pathway enrichment analysis, but solely relies on pathway definitions from the KEGG database. Furthermore, impacted pathways are determined based on Fisher’s exact test, which was shown to be particularly prone to reporting false positive pathway enrichments [5]. IMPaLA on the contrary supports the analysis of a range of different pathway databases but is limited to two different omics input layers, allowing to integrate either transcriptome and metabolome or proteome and metabolome. While PaintOmics is applicable to several model organisms (mouse, rat, fruit fly, etc.) IMPaLA is restricted to human pathway definitions only.

Here we introduce the multiGSEA R package that provides multi-omics-based pathway enrichment employing the robust GSEA algorithm and allowing to use pathway or gene set definitions from several curated databases. In its current version multiGSEA is applicable to a combination of transcriptome, proteome, and metabolome data measured in 11 different organisms, including human, mouse, or rat.

Implementation and workflow

In principle, the workflow of the multiGSEA package is composed of three essential steps: (1) prepare pathway definitions and omics data (2) single omics gene set enrichment analysis (3) combined multi-omics enrichment. These steps are graphically outlined in Fig. 1 and described in detail below:

Collecting pathway definitions, feature extraction, and mapping

Over the last decades, several pathway databases have been established. Some of which are peer-reviewed and manually curated while others follow a community-based approach to develop and refine pathways. However, often these databases contain their own format in which pathway definitions are provided, making it cumbersome to include multiple databases in an analysis workflow. The ‘graphite‘ ‘R‘ package [9] was designed to bridge this gap since it is able to provide pathway definitions from eight publicly available databases – the numbers of currently available human pathway definitions in these databases are listed in parentheses: KEGG (311) [10], Biocarta (247), Reactome (2208) [2], NCI/Nature Pathway Interaction Database (212) [11], HumanCyc (48682) [12], Panther (94) [13], smpdb (48668) [14], and PharmGKB (66) [15]. Within the first step of the multiGSEA workflow, we make use of the graphite package to retrieve pathway definitions from up to eight public databases.

Depending on the database, pathway features (nodes) are encoded with different ID formats. The KEGG database, for example, uses Entrez Gene IDs for transcripts and proteins while KEGG Compound IDs are used for metabolites. The Reactome database on the contrary stores transcripts and proteins by means of Uniprot identifiers, while ChEBI IDs are used for metabolites. Further metabolite ID formats are CAS numbers and Pubchem IDs. To solve this issue, especially when dealing with multiple pathway databases in a single analysis, we implemented an ID mapping for features of all three supported omics layers. Transcriptomics and proteomics features can be mapped to the following formats: Entrez Gene IDs, Uniprot IDs, Gene Symbols, RefSeq, or Ensembl IDs. The mapping procedure is accomplished by means of the AnnotationDbi Bioconductor package [16] and depends on the loaded annotation database such as org.Hs.eg.db for human [17].

Metabolomic features can be mapped to Comptox Dashboard specific IDs (DTXSID, DTXCID), CAS numbers, Pubchem IDs (CID, SID), KEGG Compound IDs, HMDB IDs, or ChEBI IDs. For enhanced usability we encapsulated this comprehensive metabolite mapping data set in a stand-alone AnnotationHub package called metaboliteIDmapping [18]. In its current version the package contains more than 1.1 million compounds and was collected and integrated from four different databases: Comptox DashboardFootnote 1,Footnote 2, HMDBFootnote 3, and ChEBIFootnote 4.

Fig. 1
figure1

Figure illustrating the workflow of the multiGSEA package. In step 1 pathway databases are queried, the features are extracted and mapped to user-defined ID formats. Single omics pathway enrichment using a GSEA-based approach is performed in step 2. p values from these calculations are combined in step 3 to create a multi-omics pathway enrichment

Gene set enrichment analysis

Measured omics data are necessary for the calculation of gene set enrichment scores. These data have to be loaded for each of the omics layers that have been defined in the previous step of extracting pathway-specific features from external databases. Prior to the enrichment score computation, a differential expression analysis has to be performed such that all omics features have an associated fold change and p value. The pre-processing step has to be done externally and is not part of the multiGSEA package.

In a second step, multiGSEA calculates the enrichment score by applying the fgsea R package [19] on each omics layer individually. The algorithm GSEA in its original form was first described to shed light on the mechanistic basis of Type 2 Diabetes mellitus [20]. The updated and most commonly applied version was introduced by Subramanian et al. [21] two years later. In brief, measured omics features are utilized for a differential expression testing to derive fold changes and associated p values. Ranking metrics are then used to calculate the so-called local statistic. In multiGSEA, a ranked feature list is calculated based on the direction of the fold-change and the log-transformed p value. Different ranking metrics can be chosen individually and this choice can have strong effects on the outcome of the gene set enrichment analysis [22]. In the following step, GSEA algorithms test whether gene sets accumulate at the top or bottom of those ordered gene vectors. The fgsea version used here is an efficient but yet accurate implementation of the prominent GSEA algorithm. Its performance is achieved through implementing a cumulative GSEA-statistic calculation allowing to reuse random gene set samples between different input pathways [19].

After the second part of the multiGSEA workflow, each downloaded pathway has been assigned fgsea-based enrichment scores, p values, and adjusted p values for each omics layer separately.

Combined multi-omics enrichment

To more comprehensively measure a pathway response, multiGSEA provides different approaches to compute an aggregated p value over multiple omics layers. Because no single approach for aggregating p values performs best under all circumstances, Loughin proposed basic recommendations on which method to use depending on structure and expectation of the problem [23]. If small p values should be emphasized, Fisher’s method should be chosen. In cases where p values should be treated equally, Stouffer’s method is preferable. If large p values should be emphasized, the user should select Edgington’s method. Figure 2 indicates the difference between those three methods.

Fig. 2
figure2

Figure illustrating the difference between Fisher’s combined probability test, Stouffer’s method, and Edgington’s method to aggregate multiple p values. Two times 25k p values have been randomly chosen to be subsequently combined by either of those three methods. Combined p values lower than 0.05 are classified as significant and plotted red

A first option is the Fisher’s combined probability test, which uses the p values from k independent tests (here up to three omics layers) to calculate a test statistic \(\mathrm {X}^2_F = -2 \sum _{i=n}^k ln(p_i)\). If all of the null hypotheses of the k tests are true, the test statistic will follow a \(\mathrm {X}^2\) distribution with \(2^k\) degrees of freedom [24]. Fisher’s method is asymmetrically sensitive to small p values which results in a bias for aggregated p values from multiple studies on the same null hypothesis [25]. This can be seen in Fig. 2 (Fisher) especially in those cases where one of both single p value is close to 1 and yet the combined p value is still considered to be significant, simply because the other single p value is small enough.

To circumvent this asymmetry, multiGSEA can also apply alternative methods: the Z-transform test and the weighted Z-transform test. The first algorithm is also called Stouffer’s method. Both versions make use of the fact that p values, ranging from 0 to 1, can be uniquely matched with a value in Z, representing a standard normal deviate, and vice versa. Each p value \(p_i\) from k independent tests (here omics layer) is converted into deviates \(Z_i\), with \(Z_i = \Phi ^{-1}(p_i)\) and \(\Phi\) being the standard normal cumulative distribution function. Stouffer’s method is defined as:

$$Z_s = \frac{\sum _{i=1}^{k} Z_i}{\sqrt{k}}$$

\(Z_s\) follows a standard normal distribution if the null hypothesis is true, and thus can be compared to a standard normal distribution to provide a test of the cumulative evidence [26]. As can be seen in Fig. 2 (Stouffer), this method is smoother and more balanced.

The weighted version of this method is defined by:

$$Z_s = \frac{\sum _{i=1}^{k} w_i * Z_i}{\sqrt{\sum _{i=1}^{k} w_i^2}}$$

It is still an open debate whether the weighted or unweighted version is preferential. However, it has been reported that if the weighted version is used, optimal results are obtained using weights proportional to the square root of the sample sizes [27, 28].

A third alternative method was created by Edgington and relies on untransformed p values. It was developed to combine probability values through an additive approach [29]:

$$\frac{S^k}{k!}$$

with

$$S = \sum _{i=1}^{k} p_i$$

and k being the number of individual studies. However, this is a rather conservative estimate resulting in combined probability values that are too high when \(\sum _{i=1}^k p_i > 1\). To account for this, correction terms were added to the summation:

$$\frac{S^k}{k!} - \left( {\begin{array}{c}k\\ 1\end{array}}\right) \frac{(S-1)^k}{k!} + \left( {\begin{array}{c}k\\ 2\end{array}}\right) \frac{(S-2)^k}{k!} - \dots$$

Plus and minus signs alternate and the series continues until the numerator becomes negative. Finally, the result of this progression is compared to a chosen significance level on whether to reject the null hypothesis or not. As shown in Fig. 2 (Edgington), this combination method is much more conservative compared to Fisher’s and Stouffer’s approach.

A recommendable review on those three (and three additional) aggregation methods was published by Heard and Rubin-Delanchy [30] alongside some practical advises on how to chose a suitable method.

multiGSEA allows to choose from all above described approaches for p value combination, which are provided through the metap R package [31]. Both Fisher’s combined probability test and Stouffer’s method have been shown to control both type I and type II errors well upon p value combination. However, the weighted Z-transform method was reported superior regarding type II errors [25]. We are not aware of a comparable analysis for Edgington’s method.

After computing combined p values, these can be adjusted for multiple testing. Since appropriate methods are available in R base packages, multiGSEA does not provide its own implementation. Type I and type II errors depend on each other and thus reducing type I errors through a p value adjustment will likely increase the chance of making a type II error and an appropriate trade-off has to be made [32, 33].

Finally, multiGSEA outputs a plain table listing the pathways with their single-omics and aggregated multi-omics p values and adjusted p values.

Results

Example use case

In the following, we will illustrate a use case scenario on human mitochondrial stress data. A comprehensive vignette of the multiGSEA package can be found in our git repository or at the Bioconductor package website.

Please visit the repository page to report issues, request features or provide other feedback.

Installation

For installation we recommend two ways: (i) use the BiocManager package from Bioconductor:

figurea

(ii) use the devtools library [34] to install directly from our git repository:

figureb

Example data and pathway definitions

At the beginning we need to set up several prerequisites. This includes loading the package itself and those packages that are needed to map omics feature IDs such as transcript IDs or metabolite IDs (i). We furthermore need to load the multi-omics data (ii) and we have to download the pathway definitions where the enrichment should be calculated on (iii).

(i) Load the multiGSEA R package and the packages that are needed for the mapping of omics features IDs:

figurec

Depending on the organism and omics layer for which an enrichment should be calculated the users might need different packages that provide the necessary ID mapping information. In principle, the mapping of transcript and protein IDs relies on the AnnotationDbi package [16]. In this use case we want to analyse human data, and thus need to load the org.Hs.eb.db package which provides human specific mapping information [17]. When rat or mouse omics data should be analyzed, the user needs to load the corresponding packages org.Rn.eg.db [35] or org.Mm.eg.db [36], respectively. A list of supported organisms and their respective mapping packages can be found in the vignette. The mapping information for metabolites is independent of the analyzed organism and only needs to be loaded when metabolomics data is used in the multi-omics enrichment. The metabolite mapping information is provided by the metaboliteIDmapping R package [18].

(ii) Load the multi-omics data sets:

figured

The multi-omics data set that is used in this example was originally published in its raw form by Quirós et al. [37]. In this publication the authors analyzed the mitochondrial response to four different toxicants, including Actinonin, Diclofenac, FCCP, and Mito-Block (MB), within the transcriptome, proteome, and metabolome layer. The original Actinonin data set was processed and log2 fold changes were calculated for all three omics layers. The processed data sets are deposited within the package and can be accessed with the data() command.

Right after multiple omics data sets are loaded, we need to create a suitable data structure and calculate the ranked omics features for the following GSEA calculation. multiGSEA works with nested lists where each sublist represents an omics layer. Such a data structure is initialized with the initOmicsDataStructure() command:

figuree

The feature ranks are calculated separately for each of the applied omics layers. In this example we simply use the signed and logarithm transformed p value [38] derived from the differentially expression analysis, which is implemented in the rankFeatures() command:

figuref

Please note that every other ranking metric is, of course, possible as well, and the choice is up to the user. According to Zyla et al. this decision does also have critical effects on the outcome of the gene set enrichment analysis [22]

(iii) Retrieve pathway definitions and map features to the same ID format as in your omics measurements:

figureg

In this use case we merely retrieved KEGG-based pathway definitions but depending on the organism being analyzed up to eight different pathway databases can be queried. The function getMultiOmicsFeatures retrieves the pathway definitions from the specified databases, extracts the omics features thereof, and maps those features to the ID format that is been used in the omics data. Here, it maps Entrez Gene IDs and KEGGCOMP IDs that are used in KEGG pathways for transcripts/proteins and metabolites, respectively, towards Gene Symbols and HMDB identifiers, respectively.

Run pathway enrichment

Now that we have ranked omics features and pre-formatted pathway definitions, we can calculate GSEA-based pathway enrichments for each omics layer separately by means of multiGSEA:

figureh

The pathway enrichment within multiGSEA is done by the fgsea package [19]. This package allows to efficiently and accurately calculate arbitrarily low GSEA p values for a collection of feature sets. This speedup compared to the original GSEA implementation is basically accomplished because generated random gene sets are shared between different input pathways.

The returned data frame enrichment_scores contains nested lists for each analyzed omics layer and each omics-specific sublist contains the complete gene set enrichment analysis for its respective layer.

Calculate aggregated p values

For further analysis, the function extractPvalues() creates a simple data frame where each row represents a pathway and columns represent omics related p values and adjusted p values:

figurei

This data structure can then be used to calculate the aggregated p values and the adjusted p values. As explained in the workflow section covering the combination of multiple omics pathway enrichment p values (“Combined multi-omics enrichment” section), multiGSEA utilizes three different p value combination methods. By default, combinePvalues() will apply the Z-method or Stouffer’s method [26] which has no bias towards small or large p values. The two other options are Fisher’s combined probability test [24] and Edgington’s method [29]. These can be applied by setting the parameter method to “fisher” or “edgington”, respectively. The choice to additionally correct for multiple testing is up to the user. It should be mentioned, however, that p value adjustments have an effect on both type I and II errors. Here, we used the p.adjust() command to apply a Benjamini/Hochberg correction [39].

figurej

Conclusions

The presented multiGSEA package substantially helps to minimize the drawbacks and restriction that have been identified in recent multi-omics enrichment tools. It utilizes a robust enrichment algorithm with GSEA that has been shown to keep both the type I and II error rate at a minimum. The multiGSEA package offers, furthermore, a high versatility and flexibility through the accessibility of eight different pathway databases and its support for 11 different model organisms. The user is able to calculate enrichment scores for one, two, or all three provided omics layers and has access to a comprehensive mapping of omics features IDs on the transcriptome, proteome, and metabolite level. Finally, the whole process of data retrieval, mapping of feature IDs, the calculation of pathway enrichments, and the combination of those enrichment scores is wrapped into an intuitive and easy-to-use workflow which considerably simplifies the inference of biological meaning from multi-omics data sets.

Availability and requirements

The multiGSEA package is entirely written in R and available under the GPL-3 license. The package is part of the Bioconductor project to provide open source software for bioinformatics at https://bioconductor.org/packages/multiGSEA. The current development version of the package can be found on our GitHub page at https://github.com/yigbt/multiGSEA or in the Bioconductor development branch at https://bioconductor.org/packages/devel/bioc/html/multiGSEA.html.

Project name: multiGSEA

Project home page: https://github.com/yigbt/multiGSEA,

https://bioconductor.org/packages/multiGSEA

Operating system(s): Platform independent

Programming language: R

Other requirements: No

License: GNU GPL V3.

Any restrictions to use by non-academics: No

Availability of data and materials

The datasets that have been analyzed in the use case and the vignette were originally published in its raw form by Quirós et al. in 2017: https://doi.org/10.1083/jcb.201702058. Transcriptomics data was downloaded from NCBI Geo: https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE84631. Proteomics data was retrieved from ProteomeXchange Consortium: http://proteomecentral.proteomexchange.org/cgi/GetDataset?ID=PXD006293. The metabolomics data was retrieved from the supplementary material.

Notes

  1. 1.

    ftp://newftp.epa.gov/COMPTOX/Sustainable_Chemistry_Data/Chemistry_Dashboard/PubChem_DTXSID_mapping_file.txt.

  2. 2.

    ftp://newftp.epa.gov/COMPTOX/Sustainable_Chemistry_Data/Chemistry_Dashboard/2019/April/DSSToxSDF.zip.

  3. 3.

    http://www.hmdb.ca/system/downloads/current/hmdb_metabolites.zip.

  4. 4.

    ftp://ftp.ebi.ac.uk/pub/databases/chebi/Flat_file_tab_delimited/database_accession.tsv.

Abbreviations

ChEBI:

Chemical entities of biological interest

GSEA:

Gene set enrichment analysis

GO:

Gene ontology

HMDB:

Human metabolome database

KEGG:

Kyoto encyclopedia of genes and genomes

MSigDB:

Molecular signature database

ORA:

Over-representation analysis

References

  1. 1.

    Gene Ontology Consortium. Gene Ontology Consortium: going forward. Nucleic Acids Res. 2015;43(Database issue):1049–56. https://doi.org/10.1093/nar/gku1179.

    CAS  Article  Google Scholar 

  2. 2.

    Matthews L, Gopinath G, Gillespie M, Caudy M, Croft D, de Bono B, Garapati P, Hemish J, Hermjakob H, Jassal B, Kanapin A, Lewis S, Mahajan S, May B, Schmidt E, Vastrik I, Wu G, Birney E, Stein L, D’Eustachio P. Reactome knowledgebase of human biological pathways and processes. Nucleic Acids Res. 2009;37(Database issue):619–22. https://doi.org/10.1093/nar/gkn863.

    CAS  Article  Google Scholar 

  3. 3.

    Liberzon A, Subramanian A, Pinchback R, Thorvaldsdóttir H, Tamayo P, Mesirov JP. Molecular signatures database (MSigDB) 3.0. Bioinformatics. 2011;27(12):1739–40. https://doi.org/10.1093/bioinformatics/btr260.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  4. 4.

    Khatri P, Sirota M, Butte AJ. Ten years of pathway analysis: current approaches and outstanding challenges. PLoS Comput Biol. 2012;8(2):1002375. https://doi.org/10.1371/journal.pcbi.1002375.

    CAS  Article  Google Scholar 

  5. 5.

    Nguyen TM, Shafi A, Nguyen T, Draghici S. Identifying significantly impacted pathways: a comprehensive review and assessment. Genome Biol. 2019;20(1):203. https://doi.org/10.1186/s13059-019-1790-4.

    Article  PubMed  PubMed Central  Google Scholar 

  6. 6.

    Canzler S, Schor J, Busch W, Schubert K, Rolle-Kampczyk UE, Seitz H, Kamp H, von Bergen M, Buesen R, Hackermüller J. Prospects and challenges of multi-omics data integration in toxicology. Arch Toxicol. 2020;94(2):371–88. https://doi.org/10.1007/s00204-020-02656-y.

    CAS  Article  PubMed  Google Scholar 

  7. 7.

    Hernández-de-Diego R, Tarazona S, Martínez-Mira C, Balzano-Nogueira L, Furió-Tarí P, Pappas GJ, Conesa A. PaintOmics 3: a web resource for the pathway analysis and visualization of multi-omics data. Nucleic Acids Res. 2018;46(W1):503–9. https://doi.org/10.1093/nar/gky466.

    CAS  Article  Google Scholar 

  8. 8.

    Kamburov A, Cavill R, Ebbels TM, Herwig R, Keun HC. Integrated pathway-level analysis of transcriptomics and metabolomics data with impala. Bioinformatics. 2011;27(20):2917–8. https://doi.org/10.1093/bioinformatics/btr499.

    CAS  Article  PubMed  Google Scholar 

  9. 9.

    Sales G, Calura E, Cavalieri D, Romualdi C. Graphite: a Bioconductor package to convert pathway topology to gene network. BMC Bioinform. 2012;13:20. https://doi.org/10.1186/1471-2105-13-20.

    Article  Google Scholar 

  10. 10.

    Ogata H, Goto S, Sato K, Fujibuchi W, Bono H, Kanehisa M. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 1999;27(1):29–34. https://doi.org/10.1093/nar/27.1.29.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  11. 11.

    Schaefer CF, Anthony K, Krupa S, Buchoff J, Day M, Hannay T, Buetow KH. Pid: the pathway interaction database. Nucleic Acids Res. 2009;37(Database issue):674–9. https://doi.org/10.1093/nar/gkn653.

    CAS  Article  Google Scholar 

  12. 12.

    Caspi R, Altman T, Dale JM, Dreher K, Fulcher CA, Gilham F, Kaipa P, Karthikeyan AS, Kothari A, Krummenacker M, Latendresse M, Mueller LA, Paley S, Popescu L, Pujar A, Shearer AG, Zhang P, Karp PD. The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases. Nucleic Acids Res. 2010;38(Database issue):473–9. https://doi.org/10.1093/nar/gkp875.

    CAS  Article  Google Scholar 

  13. 13.

    Mi H, Muruganujan A, Thomas PD. PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees. Nucleic Acids Res. 2013;41(Database issue):377–86. https://doi.org/10.1093/nar/gks1118.

    CAS  Article  Google Scholar 

  14. 14.

    Jewison T, Su Y, Disfany FM, Liang Y, Knox C, Maciejewski A, Poelzer J, Huynh J, Zhou Y, Arndt D, Djoumbou Y, Liu Y, Deng L, Guo AC, Han B, Pon A, Wilson M, Rafatnia S, Liu P, Wishart DS. SMPDB 2.0: big improvements to the Small Molecule Pathway Database. Nucleic Acids Res. 2014;42(Database issue):478–84. https://doi.org/10.1093/nar/gkt1067.

    CAS  Article  Google Scholar 

  15. 15.

    Whirl-Carrillo M, McDonagh EM, Hebert JM, Gong L, Sangkuhl K, Thorn CF, Altman RB, Klein TE. Pharmacogenomics knowledge for personalized medicine. Clin Pharmacol Ther. 2012;92(4):414–7. https://doi.org/10.1038/clpt.2012.96.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  16. 16.

    Pagès H, Carlson M, Falcon S, Li N. AnnotationDbi: manipulation of SQLite-based annotations in Bioconductor. 2019. R package version 1.48.0. https://bioconductor.org/packages/release/bioc/html/AnnotationDbi.html. Accessed 19 Aug 2020.

  17. 17.

    Carlson M. org.Hs.eg.db: Genome wide annotation for human. 2019. R package version 3.10.0. https://bioconductor.org/packages/release/data/annotation/html/org.Hs.eg.db.html. Accessed 25 Aug 2020.

  18. 18.

    Canzler S. metaboliteIDmapping. 2020. Bioconductor AnnotationHub package version 0.99.8. https://bioconductor.org/packages/metaboliteIDmapping. Accessed 5 Nov 2020.

  19. 19.

    Korotkevich G, Sukhov V, Sergushichev A. Fast gene set enrichment analysis. bioRxiv. 2019. https://doi.org/10.1101/060012. https://www.biorxiv.org/content/early/2019/10/22/060012.full.pdf.

  20. 20.

    Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, Houstis N, Daly MJ, Patterson N, Mesirov JP, Golub TR, Tamayo P, Spiegelman B, Lander ES, Hirschhorn JN, Altshuler D, Groop LC. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34(3):267–73. https://doi.org/10.1038/ng1180.

    CAS  Article  PubMed  Google Scholar 

  21. 21.

    Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102(43):15545–50. https://doi.org/10.1073/pnas.0506580102.

    CAS  Article  PubMed  Google Scholar 

  22. 22.

    Zyla J, Marczyk M, Weiner J, Polanska J. Ranking metrics in gene set enrichment analysis: do they matter? BMC Bioinform. 2017;18(1):256. https://doi.org/10.1186/s12859-017-1674-0.

    CAS  Article  Google Scholar 

  23. 23.

    Loughin TM. A systematic comparison of methods for combining p-values from independent tests. Comput Stat Data Anal. 2004;47(3):467–85.

    Article  Google Scholar 

  24. 24.

    Fisher SRA. Statistical methods for research workers—revised and enlarged. Edinburgh, London; 1932.

  25. 25.

    Whitlock MC. Combining probability from independent tests: the weighted Z-method is superior to Fisher’s approach. J Evol Biol. 2005;18(5):1368–73. https://doi.org/10.1111/j.1420-9101.2005.00917.x.

    CAS  Article  PubMed  Google Scholar 

  26. 26.

    Stouffer SA, Suchman EA, DeVinney LC, Star SA, Williams RM. The American soldier: adjustment during army life (studies in social psychology in world war II), vol. 1. Princeton: Princeton University Press; 1949.

    Google Scholar 

  27. 27.

    Lipták T. On the combination of independent tests. Magyar Tud Akad Mat Kutato Int Kozl. 1958;3:171–97.

    Google Scholar 

  28. 28.

    Zaykin DV. Optimally weighted Z-test is a powerful method for combining probabilities in meta-analysis. J Evol Biol. 2011;24(8):1836–41. https://doi.org/10.1111/j.1420-9101.2011.02297.x.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  29. 29.

    Edgington ES. An additive method for combining probability values from independent experiments. J Psychol. 1972;80(2):351–63.

    Article  Google Scholar 

  30. 30.

    Heard NA, Rubin-Delanchy P. Choosing between methods of combining p-values. Biometrika. 2018;105(1):239–46. https://doi.org/10.1093/biomet/asx076.

    Article  Google Scholar 

  31. 31.

    Dewey M. metap: Meta-analysis of significance values. 2020. R package version 1.3. https://cran.r-project.org/web/packages/metap/index.html.

  32. 32.

    Feise RJ. Do multiple outcome measures require p-value adjustment? BMC Med Res Methodol. 2002;2:8. https://doi.org/10.1186/1471-2288-2-8.

    Article  PubMed  PubMed Central  Google Scholar 

  33. 33.

    Perneger TV. What’s wrong with Bonferroni adjustments. BMJ. 1998;316(7139):1236–8. https://doi.org/10.1136/bmj.316.7139.1236.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  34. 34.

    Wickham H, Hester J, Chang W. devtools: tools to make developing R packages easier. 2019. R package version 2.2.1. https://CRAN.R-project.org/package=devtools. Accessed 11 Jul 2020.

  35. 35.

    Carlson M. org.Rn.eg.db: Genome wide annotation for rat. 2019. R package version 3.8.2. https://bioconductor.org/packages/release/data/annotation/html/org.Rn.eg.db.html. Accessed 25 Aug 2020.

  36. 36.

    Carlson M. org.Mm.eg.db: genome wide annotation for mouse. 2019. R package version 3.8.2. https://bioconductor.org/packages/release/data/annotation/html/org.Mm.eg.db.html. Accessed 25 Aug 2020.

  37. 37.

    Quirós PM, Prado MA, Zamboni N, D’Amico D, Williams RW, Finley D, Gygi SP, Auwerx J. Multi-omics analysis identifies ATF4 as a key regulator of the mitochondrial stress response in mammals. J Cell Biol. 2017;216(7):2027–45. https://doi.org/10.1083/jcb.201702058.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  38. 38.

    Zheng W, Li Z, Nguyen AT, Li C, Emelyanov A, Gong Z. Xmrk, kras and myc transgenic zebrafish liver cancer models share molecular signatures with subsets of human hepatocellular carcinoma. PLoS One. 2014;9(3):91179. https://doi.org/10.1371/journal.pone.0091179.

    CAS  Article  Google Scholar 

  39. 39.

    Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B (Methodol). 1995;57(1):289–300.

    Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

Open Access funding enabled and organized by Projekt DEAL. This work was financially supported by the CEFIC Long Range Initiative through funding the project C5 - XomeTox and by the European Union’s Horizon 2020 research and innovation programme under grant agreement No814426 - NanoinformaTIX. Both parties had no influence on the research topic. Open Access funding was enabled and organized by Projekt DEAL.

Author information

Affiliations

Authors

Contributions

SC implemented multiGSEA. SC and JH wrote the manuscript. All authors have read and approved the manuscript.

Corresponding author

Correspondence to Sebastian Canzler.

Ethics declarations

Ethics approval and consent to participate

No ethics approval was required for the study.

Consent for publication

Not Applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Canzler, S., Hackermüller, J. multiGSEA: a GSEA-based pathway enrichment analysis for multi-omics data. BMC Bioinformatics 21, 561 (2020). https://doi.org/10.1186/s12859-020-03910-x

Download citation

Keywords

  • Pathway enrichment
  • GSEA
  • Multi-omics
  • Bioconductor
  • Software
  • R